{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:20:24Z","timestamp":1648808424681},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T00:00:00Z","timestamp":1550275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11096-019-00793-8","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T05:10:47Z","timestamp":1550466647000},"page":"583-588","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coeliac disease detection with an IgA\/IgG-deamidated gliadin peptide based point of care test in community pharmacies"],"prefix":"10.1007","volume":"41","author":[{"given":"Michelle S.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,16]]},"reference":[{"issue":"3","key":"793_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archinte.163.3.286","volume":"163","author":"A Fasano","year":"2003","unstructured":"Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286\u201392.","journal-title":"Arch Intern Med"},{"issue":"7","key":"793_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/gut.52.7.960","volume":"52","author":"J West","year":"2003","unstructured":"West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003;52(7):960\u20135.","journal-title":"Gut"},{"issue":"6","key":"793_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823\u201336.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"793_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2014.55","volume":"109","author":"J West","year":"2014","unstructured":"West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109(5):757\u201368.","journal-title":"Am J Gastroenterol"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"h4513","DOI":"10.1136\/bmj.h4513","volume":"351","author":"L Downey","year":"2015","unstructured":"Downey L, Houten R, Murch S, Longson D. Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance. BMJ. 2015;351:h4513.","journal-title":"BMJ"},{"issue":"915","key":"793_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/pmj.78.915.31","volume":"78","author":"DS Sanders","year":"2002","unstructured":"Sanders DS, Hurlstone DP, Stokes RO, Rashid F, Milford-Ward A, Hadjivassiliou M, et al. Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J. 2002;78(915):31\u20133.","journal-title":"Postgrad Med J"},{"issue":"4","key":"793_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5694\/j.1326-5377.1977.tb130530.x","volume":"1","author":"CB Campbell","year":"1977","unstructured":"Campbell CB, Roberts RK, Cowen AE. The changing clinical presentation of coeliac disease in adults. Med J Aust. 1977;1(4):89\u201393.","journal-title":"Med J Aust"},{"issue":"6359","key":"793_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/bmj.286.6359.95","volume":"286","author":"RFA Logan","year":"1983","unstructured":"Logan RFA, Tucker G, Rifkind EA, Heading RC, Ferguson A. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960\u201379. BMJ. 1983;286(6359):95\u20137.","journal-title":"BMJ"},{"issue":"3","key":"793_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1651-2227.1988.tb10668.x","volume":"77","author":"M Maki","year":"1988","unstructured":"Maki M, Kallonen K, Lahdeaho ML, Visakorpi JK. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand. 1988;77(3):408\u201312.","journal-title":"Acta Paediatr Scand."},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jaci.2015.01.044","volume":"135","author":"P Green","year":"2015","unstructured":"Green P, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135:1099\u2013106.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"793_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00042737-200304000-00012","volume":"15","author":"DS Sanders","year":"2003","unstructured":"Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M, et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol. 2003;15(4):407\u201313.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7177","key":"793_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/bmj.318.7177.164","volume":"318","author":"H Hin","year":"1999","unstructured":"Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: case finding study. BMJ. 1999;318(7177):164\u20137.","journal-title":"BMJ"},{"issue":"9","key":"793_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.dld.2011.01.002","volume":"43","author":"K Alarida","year":"2011","unstructured":"Alarida K, Harown J, Ahmaida A, Marinelli L, Venturini C, Kodermaz G, et al. Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies. Dig Liver Dis. 2011;43(9):688\u201391.","journal-title":"Dig Liver Dis."},{"issue":"5","key":"793_CR14","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s11096-016-0368-4","volume":"38","author":"H Urwin","year":"2016","unstructured":"Urwin H, Wright D, Twigg M, McGough N. Early recognition of coeliac disease through community pharmacies: a proof of concept study. Int J Clin Pharm. 2016;38(5):1294\u2013300.","journal-title":"Int J Clin Pharm."},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12876-016-0521-5","volume":"16","author":"MS Lau","year":"2016","unstructured":"Lau MS, Mooney P, White W, Appleby V, Moreea S, Haythem I, et al. Pre-endoscopy point of care test (Simtomax- IgA\/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model. BMC Gastroenterol. 2016;16:115.","journal-title":"BMC Gastroenterol."},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-230X-13-156","volume":"13","author":"HO Wiland","year":"2013","unstructured":"Wiland HO, Henricks WH, Daly TM. Limited utilization of serologic testing in patients undergoing duodenal biopsy for celiac disease. BMC Gastroenterol. 2013;13:156.","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"793_CR17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.cgh.2015.01.010","volume":"13","author":"PD Mooney","year":"2015","unstructured":"Mooney PD, Wong SH, Johnston AJ, Kurien M, Avgerinos A, Sanders DS. Increased detection of celiac disease with measurement of deamidated gliadin peptide antibody before endoscopy. Clin Gastroenterol Hepatol. 2015;13(7):1278\u201384.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00793-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T19:11:56Z","timestamp":1581793916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,16]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00793-8","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,16]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No funding was received for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Professor David Sanders has received funding from Dr Schaer (a gluten-free food manufacturer) and Tillotts Pharma (distributor of a point of care test for celiac disease) for investigator led studies. None of the funding sources had any input in the study design, access to study data, interpretation of the findings or drafting of the manuscript. Dr Michelle Lau has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}